XML 114 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Total
At-The-Market Offering
Private Investment In Public Entity Offering
ADDITIONAL PAID-IN CAPITAL
ADDITIONAL PAID-IN CAPITAL
At-The-Market Offering
ADDITIONAL PAID-IN CAPITAL
Private Investment In Public Entity Offering
ACCUMULATED OTHER COMPREHENSIVE LOSS
ACCUMULATED DEFICIT
ORDINARY SHARES
ORDINARY SHARES
COMMON STOCK
ORDINARY SHARES
COMMON STOCK
At-The-Market Offering
ORDINARY SHARES
COMMON STOCK
Private Investment In Public Entity Offering
DEFERRED SHARES
COMMON STOCK
Beginning balance (in shares) at Dec. 31, 2022                   42,631,794     1
Beginning balance at Dec. 31, 2022 $ 181,280     $ 458,825     $ (16,867) $ (261,146)   $ 440     $ 28
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of ordinary shares under ATM facility or PIPE offering, net of issuance costs (in shares)                     2,937,622 16,076,750  
Issuance of ordinary shares under ATM facility or PIPE offering, net of issuance costs   $ 28,120 $ 116,815   $ 28,091 $ 116,652         $ 29 $ 163  
Issuance of warrants to purchase ordinary shares 687     687                  
Exercise of share options (in shares)                 166,801 166,801      
Exercise of share options 2                 $ 2      
Issuance of ordinary shares to settle vested restricted stock units (in shares)                 69,120 78,022      
Issuance of ordinary shares to settle vested restricted stock units 0     (1)           $ 1      
Cancellation of deferred share (in shares)                         (1)
Cancellation of deferred share 0     28                 $ (28)
Issuance of ordinary shares under employee share purchase plan (in shares)                   52,482      
Issuance of ordinary shares under employee share purchase plan 351     351                  
Shares tendered for withholding taxes (265)     (265)                  
Share-based compensation expense 17,277     17,277                  
Unrealized loss on foreign currency translation (59)           (59)            
Net loss $ (118,464)             (118,464)          
Ending balance (in shares) at Dec. 31, 2023 61,943,471                 61,943,471     0
Ending balance at Dec. 31, 2023 $ 225,744     621,645     (16,926) (379,610)   $ 635     $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Issuance of ordinary shares under ATM facility or PIPE offering, net of issuance costs (in shares)                     2,509,798    
Issuance of ordinary shares under ATM facility or PIPE offering, net of issuance costs   $ 26,219     $ 26,194           $ 25    
Issuance of warrants to purchase ordinary shares (in shares)                   3,752,050      
Issuance of warrants to purchase ordinary shares $ 37,258     37,220           $ 38      
Exercise of share options (in shares) 189,214               189,214 189,214      
Exercise of share options $ 221     219           $ 2      
Issuance of ordinary shares to settle vested restricted stock units (in shares)                 83,527 83,527      
Issuance of ordinary shares to settle vested restricted stock units 0     (1)           $ 1      
Issuance of ordinary shares under employee share purchase plan (in shares)                   74,155      
Issuance of ordinary shares under employee share purchase plan 365     364           $ 1      
Shares tendered for withholding taxes (239)     (239)                  
Share-based compensation expense 19,517     19,517                  
Unrealized loss on foreign currency translation 732           732            
Net loss $ (155,122)             (155,122)          
Ending balance (in shares) at Dec. 31, 2024 68,552,215                 68,552,215     0
Ending balance at Dec. 31, 2024 $ 154,695     $ 704,919     $ (16,194) $ (534,732)   $ 702     $ 0